Skip to content

A randomized controlled trial to evaluate the effectiveness of personalized genetic breast cancer risk feedback for non-breast cancer women

A randomized controlled trial to evaluate the effectiveness of personalized genetic breast cancer risk feedback for non-breast cancer women - Breast cancer risk feedback RCT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000026768
Enrollment
200
Registered
2017-04-17
Start date
2017-04-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer prevention behavior

Interventions

Personalized breast cancer risk feedback based on individuals&#39
genetic polymorohism and their lifestyles Personalized breast cancer risk feedback based on individuals&#39

Sponsors

Division of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Individuals who had a diagnostic test at Aichi Cancer Center 2.Individuals who are not diagnosed with breast cancer 3.30-69 years old women 4.no past history of cancer 5. Individuals who sign the consent document after explanation of this study

Exclusion criteria

Exclusion criteria: 1.Individuals who need regular follow-up after their initial medical examinations. 2.Individuals who had a commercial genetic testing

Design outcomes

Primary

MeasureTime frame
Frequency of breast self-examination

Secondary

MeasureTime frame
Frequency and type of breast cancer screening, Lifestyle changes (BMI, physical activity, alcohol consumption, etc)

Countries

Japan

Contacts

Public ContactKeitaro Matsuo

Aichi Cancer Center Division of Molecular and Clinical Epidemiology

molemed3@aichi-cc.jp0528517750

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026